Peer-influenced content. Sources you trust. No registration required. This is HCN.

Cleveland Clinic | Consult QDImproving Survivorship for Women with Bladder Cancer

Bladder cancer survival rates have improved, but quality of life issues persist for women survivors. Traditional radical cystectomy often removes bladder plus pelvic organs, causing surgical menopause, sexual dysfunction, and other cascading health effects that impact long-term survivorship.


⚕️ Key Clinical Considerations ⚕️

  • Surgical approach evolution. Modern organ-sparing techniques show effective cancer control while preserving anatomy and function.
  • Multidisciplinary survivorship care. Coordinated management addressing physical, sexual, and psychological impacts beyond cancer treatment.
  • Gender-specific complications. Women face unique challenges including surgical menopause, bone health risks, cardiovascular effects, and sexual dysfunction.
  • Patient counseling priorities. Open conversations about treatment options, functional outcomes, and long-term quality of life considerations.

🎯 Clinical Practice Impact 🎯

  • More women entering urologic oncology are bringing survivorship issues to research forefront.
  • Interim imaging during neoadjuvant chemotherapy may help preserve eligibility for vaginal-sparing procedures.
  • Clinical focus shifting from cancer control alone to comprehensive survivorship programs that address unique needs of female patients.

More in Bladder Cancer

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form